Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balasubramanian Krishnamurthy

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Nature Cell Biology|February 26, 2024
METTL3 restrains autoimmunity in β-cellsBalasubramanian Krishnamurthy, Helen E Thomas
Diabetes Care|December 22, 2019
Comment on Trinh et al. Successful Treatment of Immune Checkpoint Inhibitor-Induced Diabetes With Infliximab. Diabetes Care 2019;42:e153-e154Anna Galligan, Balasubramanian Krishnamurthy, Thomas W Kay
European Journal of Immunology|June 16, 2011
Reducing or increasing β-cell apoptosis without inflammation does not affect diabetes initiation in neonatal NOD miceEmma M Carrington, Cameron Kos, Yifan Zhan, et al.
Endocrinology, Diabetes & Metabolism Case Reports|May 5, 2017
An intrasellar pituitary adenoma-gangliocytoma presenting as acromegalyMelissa H Lee, Penelope McKelvie, Balasubramanian Krishnamurthy, et al.
Journal of Autoimmunity|April 17, 2016
Analysis of antigen specific T cells in diabetes - Lessons from pre-clinical studies and early clinical trialsBalasubramanian Krishnamurthy, Claudia Selck, Jonathan Chee, et al.
Gynecologic Oncology Reports|July 5, 2022
Massive hypertriglyceridemia associated with paclitaxel; a case reportAnojian Koneshamoorthy, Danielle Hulse, Chia Yuen Chong, et al.
Frontiers in Immunology|June 22, 2023
Monitoring immunomodulation strategies in type 1 diabetesBalasubramanian Krishnamurthy, Matthew Lacorcia, Thomas W H Kay, et al.
Annals of the New York Academy of Sciences|November 22, 2012
Proinflammatory cytokines contribute to development and function of regulatory T cells in type 1 diabetesHelen E Thomas, Kate L Graham, Jonathan Chee, et al.
Inflammation & Allergy Drug Targets|April 19, 2011
NF-κB in type 1 diabetesYuxing Zhao, Balasubramanian Krishnamurthy, Zia U A Mollah, et al.
Frontiers in Immunology|December 18, 2018
IFNγ-Induced MHC Class II Expression on Islet Endothelial Cells Is an Early Marker of Insulitis but Is Not Required for Diabetogenic CD4<sup>+</sup> T Cell MigrationNicholas A Scott, Yuxing Zhao, Balasubramanian Krishnamurthy, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Nature Cell Biology|February 26, 2024
METTL3 restrains autoimmunity in β-cellsBalasubramanian Krishnamurthy, Helen E Thomas
Diabetes Care|December 22, 2019
Comment on Trinh et al. Successful Treatment of Immune Checkpoint Inhibitor-Induced Diabetes With Infliximab. Diabetes Care 2019;42:e153-e154Anna Galligan, Balasubramanian Krishnamurthy, Thomas W Kay
European Journal of Immunology|June 16, 2011
Reducing or increasing β-cell apoptosis without inflammation does not affect diabetes initiation in neonatal NOD miceEmma M Carrington, Cameron Kos, Yifan Zhan, et al.
Endocrinology, Diabetes & Metabolism Case Reports|May 5, 2017
An intrasellar pituitary adenoma-gangliocytoma presenting as acromegalyMelissa H Lee, Penelope McKelvie, Balasubramanian Krishnamurthy, et al.
Journal of Autoimmunity|April 17, 2016
Analysis of antigen specific T cells in diabetes - Lessons from pre-clinical studies and early clinical trialsBalasubramanian Krishnamurthy, Claudia Selck, Jonathan Chee, et al.
Gynecologic Oncology Reports|July 5, 2022
Massive hypertriglyceridemia associated with paclitaxel; a case reportAnojian Koneshamoorthy, Danielle Hulse, Chia Yuen Chong, et al.
Frontiers in Immunology|June 22, 2023
Monitoring immunomodulation strategies in type 1 diabetesBalasubramanian Krishnamurthy, Matthew Lacorcia, Thomas W H Kay, et al.
Annals of the New York Academy of Sciences|November 22, 2012
Proinflammatory cytokines contribute to development and function of regulatory T cells in type 1 diabetesHelen E Thomas, Kate L Graham, Jonathan Chee, et al.
Inflammation & Allergy Drug Targets|April 19, 2011
NF-κB in type 1 diabetesYuxing Zhao, Balasubramanian Krishnamurthy, Zia U A Mollah, et al.
Frontiers in Immunology|December 18, 2018
IFNγ-Induced MHC Class II Expression on Islet Endothelial Cells Is an Early Marker of Insulitis but Is Not Required for Diabetogenic CD4<sup>+</sup> T Cell MigrationNicholas A Scott, Yuxing Zhao, Balasubramanian Krishnamurthy, et al.
Pageof 6